SearcharxivSearch

arXiv subjects

Ergys Subashi

Publications and source records attributed to Ergys Subashi.

2 recordsLinked to original sources

Feasibility of a General-Purpose Deep Learning Dose Engine: A Multi-Site Validation Study

Conventional radiotherapy dose calculation algorithms are often computationally slow and non-differentiable, creating bottlenecks for online adaptive radiotherapy (ART) and limiting end-to-end automatic planning. Deep learning provides consistent inference performance and a differentiable framework essential for rapid optimization. In this study, we developed a generalized, site-independent deep learning dose engine using a beamlet-based input strategy. This establishes a computationally consistent and differentiable module that enables end-to-end training for autoplanning while maintaining accuracy across diverse geometries. A dataset of 3,600 plans from 120 patients across six anatomical sites was used to train two 3D convolutional neural networks, a standard U-Net and a Cascade U-Net, to predict 3D dose distributions from CT images and divergent MLC/jaw projections. Performance was validated via 3D gamma analysis on an independent cohort of 60 VMAT plans. The optimal model (U-Net with MAE loss) achieved a mean gamma passing rate of $98.9 \pm 1.6\%$ (3%/2mm, 10% threshold). Performance remained robust across all sites (passing rates $>98\%$), demonstrating that the beamlet-based strategy generalizes effectively to complex geometries without site-specific training. These results indicate that a single, site-independent model can calculate radiotherapy dose distributions with clinical accuracy. This differentiable engine is highly suitable for integration into end-to-end automatic planning, online ART, and secondary dose verification workflows.

physics.med-ph

Review: Adaptive Radiation Therapy for Head and Neck Cancer

The future of ART in head and neck cancer is just beginning. Novel technologies have pushed the boundary of what is possible in terms of techniques to identify biomarkers for adaptation as well as innovative devices specialized to respond to these adaptations, sometimes in real-time. Important interdisciplinary steps must be taken moving forward to ensure the safe deployment of these new techniques, such as rigorous quality assurance evaluations from medical physicists, clinical trials from physicians, and comprehensive testing from vendors prior to release. In summary, we aimed not to provide a single correct answer for the optimal implementation of ART in the era of imaging biomarkers, but to encourage the field to collaborate and bring each idea discussed here together to overcome current barriers and deliver the best treatment possible to the patient.

physics.med-ph